Literature DB >> 32388409

A potential protective effect of metformin in adenoid cystic carcinoma.

Peter J Lancione1, Bhavna Kumar2, Songzhu Zhao3, Edmund A Mroz4, Guy Brock5, James W Rocco6, Ricardo L Carrau7, Amit Agrawal8, Nolan Seim9, Stephen Y Kang10, Enver Ozer11, Matthew O Old12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32388409      PMCID： PMC9017546          DOI： 10.1016/j.oraloncology.2020.104726

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.972


× No keyword cloud information.
  36 in total

1.  Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality.

Authors:  J Fordice; C Kershaw; A El-Naggar; H Goepfert
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1999-02

2.  Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases.

Authors:  R H Spiro; A G Huvos; E W Strong
Journal:  Am J Surg       Date:  1974-10       Impact factor: 2.565

3.  Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma.

Authors:  Allen S Ho; Angelica Ochoa; Gowtham Jayakumaran; Ahmet Zehir; Cristina Valero Mayor; Justin Tepe; Vladimir Makarov; Martin G Dalin; Jie He; Mark Bailey; Meagan Montesion; Jeffrey S Ross; Vincent A Miller; Lindsay Chan; Ian Ganly; Snjezana Dogan; Nora Katabi; Petros Tsipouras; Patrick Ha; Nishant Agrawal; David B Solit; P Andrew Futreal; Adel K El Naggar; Jorge S Reis-Filho; Britta Weigelt; Alan L Ho; Nikolaus Schultz; Timothy A Chan; Luc Gt Morris
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

Review 4.  Adenoid cystic carcinoma of the head and neck--An update.

Authors:  Andrés Coca-Pelaz; Juan P Rodrigo; Patrick J Bradley; Vincent Vander Poorten; Asterios Triantafyllou; Jennifer L Hunt; Primož Strojan; Alessandra Rinaldo; Missak Haigentz; Robert P Takes; Vanni Mondin; Afshin Teymoortash; Lester D R Thompson; Alfio Ferlito
Journal:  Oral Oncol       Date:  2015-05-02       Impact factor: 5.337

Review 5.  Adenoid cystic carcinoma of the trachea.

Authors:  T Azar; F W Abdul-Karim; H M Tucker
Journal:  Laryngoscope       Date:  1998-09       Impact factor: 3.325

6.  Prognostic factors for long term results of the treatment of patients with malignant submandibular gland tumors.

Authors:  V L Vander Poorten; A J Balm; F J Hilgers; I B Tan; B M Loftus-Coll; R B Keus; A A Hart
Journal:  Cancer       Date:  1999-05-15       Impact factor: 6.860

7.  Effect of metformin on the incidence of head and neck cancer in diabetics.

Authors:  Yung-Chang Yen; Charlene Lin; Shih-Wei Lin; Yung-Song Lin; Shih-Feng Weng
Journal:  Head Neck       Date:  2014-07-11       Impact factor: 3.147

8.  Incidence of adenoid cystic carcinoma in nova scotia: 30-year population-based epidemiologic study.

Authors:  James P Bonaparte; Rob Hart; Jonathan Trites; Mark S Taylor
Journal:  J Otolaryngol Head Neck Surg       Date:  2008-10

Review 9.  Adenoid cystic carcinoma of the head and neck: a review.

Authors:  Patrick J Bradley
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2004-04       Impact factor: 2.064

10.  Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.

Authors:  Renata Ferrarotto; Yoshitsugu Mitani; Lixia Diao; Irene Guijarro; Jing Wang; Patrick Zweidler-McKay; Diana Bell; William N William; Bonnie S Glisson; Michael J Wick; Ann M Kapoun; Amita Patnaik; Gail Eckhardt; Pamela Munster; Leonardo Faoro; Jakob Dupont; J Jack Lee; Andrew Futreal; Adel K El-Naggar; John V Heymach
Journal:  J Clin Oncol       Date:  2016-11-21       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.